ANAPLASTIC LYMPHOMA KINASE

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:25:17 GMT 2023` Edited by `admin` on `Sat Dec 16 14:25:17 GMT 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	4M56WLI1MN
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ANAPLASTIC LYMPHOMA KINASE

Common Name

English

ALK TYROSINE KINASE RECEPTOR

Systematic Name

English

ALK

Common Name

English

CD246

Code

English

CD-246

Code

English

Code System Code Type Description

FDA UNII

4M56WLI1MN

Created by admin on Sat Dec 16 14:25:18 GMT 2023 , Edited by admin on Sat Dec 16 14:25:18 GMT 2023

PRIMARY

WIKIPEDIA

ANAPLASTIC LYMPHOMA KINASE

Created by admin on Sat Dec 16 14:25:18 GMT 2023 , Edited by admin on Sat Dec 16 14:25:18 GMT 2023

PRIMARY

UNIPROT

Q9UM73

Created by admin on Sat Dec 16 14:25:18 GMT 2023 , Edited by admin on Sat Dec 16 14:25:18 GMT 2023

PRIMARY

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_151
N	1_226
N	1_267
N	1_306
N	1_393
N	1_406
N	1_427
N	1_545
N	1_553
N	1_609
N	1_691
N	1_790
N	1_845
N	1_846
N	1_868
N	1_968

Related Record Type Details


					7DR7JMB8BH

X-376

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					J8AY0Z4CBP

CEP-11981

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					6L7WLR552I

5H-BENZO(B)CARBAZOLE-3-CARBONITRILE, 9-ETHYL-6,11-DIHYDRO-8-(4-((2-HYDROXYETHYL)AMINO)-1-PIPERIDINYL)-6,6-DIMETHYL-11-OXO-

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					HYW8DB273J

BRIGATINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					QB7KTQ7VW9

ENVONALKIB

INHIBITOR -> TARGET

Amount:


					HP4L6MXF10

ASP-3026

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					08O3FQ4UNP

REPOTRECTINIB

INHIBITOR -> TARGET

Amount:


					53AH36668S

Crizotinib

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					SMA5ZS5B22

ENSARTINIB

INHIBITOR -> TARGET

Amount:


					Z8A6022P3J

BELIZATINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					K418KG2GET

CERITINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					O3MNS8782H

CEP-37440

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					L5ORF0AN1I

ENTRECTINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					4T3Z98RR86

Unecritinib

INHIBITOR -> TARGET

Amount:


					5BKJ4Z6RBU

Zotizalkib

INHIBITOR -> TARGET

Interaction Type:

IN-VITRO, IN-VIVO

Amount:


					LIJ4CT1Z3Y

ALECTINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					OSP71S83EU

LORLATINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					Z5F65W1YAZ

IRUPLINALKIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL